Volume 18, Issue 4 (2026)

Feasibility of Applying Proton Minibeam Technology on the Proton Therapy Complex “Prometheus”
Feasibility of Applying Proton Minibeam Technology on the Proton Therapy Complex “Prometheus”

Key words: radiation therapy; proton therapy; radiochromic films; mathematical modeling; TOPAS MC.

2026, Volume 18, Issue 4, page 5
Full text of the article: HTML PDF
62
21
  • Abstract
  • References
  • How to cite

Spatial fractionation of proton beams is being considered as a new strategy to reduce the probability of side-effects in radiation therapy on the proton therapy complex (PTC) “Prometheus”. By collimating the beams to submillimeter dimensions, the dose profile at the target surface consists of alternating high- and low-dose regions. This promotes sparing of normal tissues along the beam path through the activation of various biological mechanisms.

The aim of the study was to implement the minibeam method on the PTC “Prometheus” and to experimentally assess the quality of the resulting dose distribution.

Materials and Methods. Collimation of the primary beam was achieved using brass multislit collimators. Mathematical modeling of the experiment was performed, and a phantom was irradiated from one and from two opposite directions. For effective summation of two fields and to achieve a homogeneous dose distribution in the target, intensity and energy modulation of the proton beams entering the collimator was carried out. To reduce errors caused by collimator deviation relative to the beam axis, a quality assurance system for collimator positioning on the treatment table was developed. Under the control of a scintillation detector and a laser positioner, positioning accuracy was within 0.2°. GafChromic EBT3 radiochromic films (Ashland, USA) were used as dosimeters.

Results. When comparing calculated and experimental data, 90% of the distribution points matched the mathematical model according to the γ criterion (3%/3 mm). The quality of the minibeam field was assessed using the following parameters: valley-to-peak dose ratio; collimator throughput; ratio of the dose without the collimator to the dose with the collimator; and dose homogeneity index in the target. The obtained results met the quality assurance criteria for standard radiation therapy.

Conclusion. Irradiation with proton minibeams using brass collimators is feasible on the PTC “Prometheus”. A uniform dose distribution in the target area was experimentally achieved. The uniformity of coverage, the absence of local dose excesses, and the high dose gradient at the distal edge suggest that the described irradiation technique can be implemented on biological specimens.

1.         Prezado Y., Fois G.R. Proton-minibeam radiation therapy: a proof of concept. Med Phys 2013; 40(3): 031712, https://doi.org/10.1118/1.4791648.

2.         Dilmanian F.A., Qu Y., Feinendegen L.E., Peña L.A., Bacarian T., Henn F.A., Kalef-Ezra J., Liu S., Zhong Z., McDonald J.W. Tissue-sparing effect of X-ray microplanar beams particularly in the CNS: is a bystander effect involved? Exp Hematol 2007; 35(4 Suppl 1): 69–77, https://doi.org/10.1016/j.exphem.2007.01.014.

3.         Sammer M., Teiluf K., Girst S., Greubel C., Reindl J., Ilicic K., Walsh D.W.M., Aichler M., Walch A., Combs S.E., Wilkens J.J., Dollinger G., Schmid T.E. Beam size limit for pencil minibeam radiotherapy determined from side effects in an in-vivo mouse ear model. PLoS One 2019; 14(9): e0221454, https://doi.org/10.1371/journal.pone.0221454.

4.         Sammer M., Zahnbrecher E., Dobiasch S., Girst S., Greubel C., Ilicic K., Reindl J., Schwarz B., Siebenwirth C., Walsh D.W.M., Combs S.E., Dollinger G., Schmid T.E. Proton pencil minibeam irradiation of an in-vivo mouse ear model spares healthy tissue dependent on beam size. PLoS One 2019; 14(11): e0224873, https://doi.org/10.1371/journal.pone.0224873.

5.         Prezado Y., Jouvion G., Hardy D., Patriarca A., Nauraye C., Bergs J., González W., Guardiola C., Juchaux M., Labiod D., Dendale R., Jourdain L., Sebrie C., Pouzoulet F. Proton minibeam radiation therapy spares normal rat brain: long-term clinical, radiological and histopathological analysis. Sci Rep 2017; 7(1): 14403, https://doi.org/10.1038/s41598-017-14786-y.

6.         Sammer M., Rousseti A., Girst S., Reindl J., Dollinger G. Longitudinally heterogeneous tumor dose optimizes proton broadbeam, interlaced minibeam, and FLASH therapy. Cancers (Basel) 2022; 14(20): 5162, https://doi.org/10.3390/cancers14205162.

7.         De Marzi L., Patriarca A., Nauraye C., Hierso E., Dendale R., Guardiola C., Prezado Y. Implementation of planar proton minibeam radiation therapy using a pencil beam scanning system: a proof of concept study. Med Phys 2018; 45(11): 5305–5316, https://doi.org/10.1002/mp.13209.

8.         Schneider T., De Marzi L., Patriarca A., Prezado Y. Advancing proton minibeam radiation therapy: magnetically focussed proton minibeams at a clinical centre. Sci Rep 2020; 10(1): 1384, https://doi.org/10.1038/s41598-020-58052-0.

9.         Sotiropoulos M., Prezado Y. A scanning dynamic collimator for spot-scanning proton minibeam production. Sci Rep 2021; 11(1): 18321, https://doi.org/10.1038/s41598-021-97941-w.

10.        Reaz F., Sitarz M.K., Traneus E., Bassler N. Parameters for proton minibeam radiotherapy using a clinical scanning beam system. Acta Oncol 2023; 62(11): 1561–1565, https://doi.org/10.1080/0284186X.2023.2266125.

11.        Merzlikin G.V., Skotnikova N.A., Adarova A.I., Chernukha A.E., Solovev A.N., Ivanov S.A., Koryakin S.N., Kanavin A.P., Saburov V.O. Verification of angular properties of a divergent pencil beam of the Prometheus therapeutic facility. Bulletin of the Lebedev Physics Institute 2024; 51(11): 450–457, https://doi.org/10.3103/s1068335624601274.

12.        Kataria T., Sharma K., Subramani V., Karrthick K.P., Bisht S.S. Homogeneity index: an objective tool for assessment of conformal radiation treatments. J Med Phys 2012; 37(4): 207–213, https://doi.org/10.4103/0971-6203.103606.

13.        Grégoire V., Mackie T.R. State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No.83). Cancer Radiother 2011; 15(6–7): 555–559, https://doi.org/10.1016/j.canrad.2011.04.003.

14.        Pryanichnikov A., Sokunov V.V., Shemyakov A.E. Some results of the clinical use of the proton therapy complex “Prometheus”. Phys Part Nuclei Lett 2018; 15(7): 981–985, https://doi.org/10.1134/S1547477118070592.

15.        Golovanova O.Yu., Merzlikin G.V., Saburov V.O., Koryakin S.N. Otsenka vozmozhnosti primeneniya prodol'no-geterogennogo oblucheniya mini-puchkami protonov. V kn.: Perspektivnye napravleniya v onkologii, radiologii i radiobiologii: materialy IX konferentsii molodykh uchenykh, posvyashchennoy pamyati akademika A.F. Tsyba [Assessing the feasibility of using longitudinal heterogeneous irradiation with proton minibeams. In: Promising directions in oncology, radiology, and radiobiology: proceedings of the IX Conference of Young Scientists dedicated to the memory of Academician A.F. Tsyb]. Obninsk; 2023; p. 50.

16.        Kotb O.M., Solovev A.N., Saburov V.O., Potetnya V.I., Koryakina E.V., Adarova A.I., Lepilina O.G., Koryakin S.N., Ivanov S.A., Kaprin A.D. Response of the FBX aqueous chemical dosimeter to high energy proton and electron beams used for radiotherapy research. Radiation Physics and Chemistry 2024; 216: 111451, https://doi.org/10.1016/j.radphyschem.2023.111451.

17.        Perl J., Shin J., Schumann J., Faddegon B., Paganetti H. TOPAS: an innovative proton Monte Carlo platform for research and clinical applications. Med Phys 2012; 39(11): 6818–6837, https://doi.org/10.1118/1.4758060.

18.        Niroomand-Rad A., Chiu-Tsao S.T., Grams M.P., Lewis D.F., Soares C.G., Van Battum L.J., Das I.J., Trichter S., Kissick M.W., Massillon-Jl G., Alvarez P.E., Chan M.F. Report of AAPM Task Group 235 Radiochromic Film Dosimetry: an update to TG-55. Med Phys 2020; 47(12): 5986–6025, https://doi.org/10.1002/mp.14497.

19.        Palmans H., Andreo P., Huq M.S., Seuntjens J., Christaki K.E., Meghzifene A. Dosimetry of small static fields used in external photon beam radiotherapy: summary of TRS-483, the IAEA-AAPM international code of practice for reference and relative dose determination. Med Phys 2018; 45(11): e1123–e1145, https://doi.org/10.1002/mp.13208.

20.        Grilj V., Brenner D.J. LET dependent response of GafChromic films investigated with MeV ion beams. Phys Med Biol 2018; 63(24): 245021, https://doi.org/10.1088/1361-6560/aaf34a.

21.        Mynampati D.K., Yaparpalvi R., Hong L., Kuo H.C., Mah D. Application of AAPM TG 119 to volumetric arc therapy (VMAT). J Appl Clin Med Phys 2012; 13(5): 3382, https://doi.org/10.1120/jacmp.v13i5.3382.

22.        Reaz F., Traneus E., Bassler N. Commissioning of a multislit collimator system for experimental pMBRT studies with uniform target dose. Phys Med Biol 2025; 70(13): 10.1088/1361-6560/ade04b, https://doi.org/10.1088/1361-6560/ade04b.


Golovanova O.Yu., Merzlikin G.V., Kaprin A.D., Soloviev A.N., Saburov V.O., Koryakin S.N. Feasibility of applying proton minibeam technology on the proton therapy complex “Prometheus”. Sovremennye tehnologii v medicine 2026; 18(4): 5, https://doi.org/10.17691/stm2026.18.4.01